Identifiers
Database identifiers and provenance.
- Ligand ID
IHP- PDB
6qx9- UniProt (similar protein)
Q9BUQ8- Target protein
- PA2840
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 660.0
- LogP ≤ 5 -3.13
- H-bond donors ≤ 5 12
- H-bond acceptors ≤ 10 12
- Rotatable bonds ≤ 10 12
- TPSA ≤ 140 Ų 400.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)OC1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O
InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)
IMQLKJBTEOYOSI-UHFFFAOYSA-NIMQLKJBTEOYOSI-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF08082' 'PF08083
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand IHP →
- PDB RCSB structure 6qx9 →
- UniProt UniProt Q9BUQ8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “IHP”) →
Other binders for this protein
Quick navigation to other ligands bound to PA2840.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).